Anti-influenza A(H5N1) virus activities of a novel polyoxometalate in vitro and in vivo

Kun Xu,Lei Hou,Songtao Yang,Hongfang Wang,Xinyu Wu,Ming Shi,Xiuzhi Zhang,Juan Li,Xianzhu Xia
DOI: https://doi.org/10.3969/j.issn.1671-8259.2007.06.009
2007-01-01
Abstract:Objective: To study anti-influenza virus A (H5N1) activity of a novel polyoxometalate and in vivo. Methods: We detected toxicity of the title compound on MDCK and inhibition on H5N1 virus infection by cytopathic effects combined with MTT assay. To understand polyoxometalates therapeutical effect on this virus, we used the mouse model. Mice were infected with H5N1 virus at 5LD 50 dose by intranasally inoculation. Results: TC0 of the title compound was 190.55 mg/L. The title compound showed a significant inhibitory effect on H5N1 compared with that in positive group. In vitro experiment showed polyoxometalates LD50 on H5N1 was 13.45 mg/L. Therapy index (TI) of the title compound was 67.40, which was higher than that of AMA. The inhibitory rate of the 25 mg/kg group was 166.16%, and prolonged survival rate was 28.36%. Conclusion: The novel polyoxometalate has better inhibitory effect on H5N1 virus.
What problem does this paper attempt to address?